Evidence map›Paper›PMID 30518945›Full record

ArticleJournal of human genetics2019

The effect of copy number variations in chromosome 16p on body weight in patients with intellectual disability.

Fátima Gimeno-Ferrer, David Albuquerque, Carola Guzmán Luján, Goitzane Marcaida Benito, Cristina Torreira Banzas, Alfredo Repáraz-Andrade, Virginia Ballesteros Cogollos, Montserrat Aleu Pérez-Gramunt, Enrique Galán Gómez, Inés Quintela and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Fátima Gimeno-FerrerGenomics Group, Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain.
David AlbuquerqueGenomics Group, Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain.ORCID http://orcid.org/0000-0001-8899-9020
Carola Guzmán LujánLaboratory of Molecular Genetics, Clinical Analysis Service, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
Goitzane Marcaida BenitoGenomics Group, Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain.
Cristina Torreira BanzasGenetics and Molecular Pathology Unit, Hospital Álvaro Cunqueiro de Vigo, Vigo, Spain.
Alfredo Repáraz-AndradeGenetics and Molecular Pathology Unit, Hospital Álvaro Cunqueiro de Vigo, Vigo, Spain.ORCID http://orcid.org/0000-0001-5682-9457
Virginia Ballesteros CogollosNeuropediatrics Service, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
Montserrat Aleu Pérez-GramuntNeuropediatrics Service, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
Enrique Galán GómezUnit of Genetic Paediatrics, Hospital Materno Infantil, Badajoz, Spain.ORCID http://orcid.org/0000-0002-9516-8230
Inés QuintelaMedicina Xenómica Group, Centro Nacional de Genotipado - Plataforma de Recursos Biomoleculares y Bioinformáticos, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
Raquel Rodríguez-LópezGenomics Group, Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain. rodriguez_raqlop@gva.es.
Hospital General Universitario De Valencia · ESUniversity Hospital Complex Of Vigo · ESHospital Materno-Infantil · ESUniversidade de Santiago de Compostela · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Syndromic monogenic obesity is a rare and severe early-onset form of obesity. It is characterized by intellectual disability, congenital malformations, and/or dysmorphic facies. The diagnosis of patients is challenging due to the genetic heterogenicity of this condition. However, the use of microarray technology in combination with public databases has been successful on genotype-phenotype correlations, especially for body mass index (BMI) alteration. In this study, the relationship between copy number variations (CNVs) detected by microarray mapping on 16p region and BMI alterations in syndromic patients were assessed. In order to achieve this goal, 680 unrelated Spanish children with intellectual disability were included. 16p region was characterized by using microarray platforms. All detected variants were classified as: (I) one previously non-described 10-Mb duplication in 16p13.2p12.3 region considered causal of intellectual disability and severe overweight, and (II) eleven 16p11.2 CNVs of low prevalence but with recurrence in syndromic patients with severe BMI alteration (nine proximal and two distal). Proximal 16p11.2 CNVs have a dose-dependent effect: underweight in carriers of duplication and obesity in carriers of deletion. KCTD13 was identified as a possible candidate gene for BMI alteration on proximal syndromes, whereas SH2B1 gene was identified as candidate for distal syndromes. The results shown in this paper suggest that syndromic patients could constitute a reliable model to evaluate hypothalamic satiety and obesity disorders as well as generate a wide expectation for primary prevention of comorbidities. Furthermore, 16p13.2p12.3 showed to be an important region on the regulation of body fatness.

Indexed as

Chromosomes, Human, Pair 16DNA Copy Number VariationsAdaptor Proteins, Signal TransducingAdolescentBody Mass IndexBody WeightChildChromosome DeletionCohort StudiesFemaleHumansIntellectual DisabilityMaleNuclear ProteinsObesityPhenotypeAdaptor Proteins, Signal TransducingKCTD13 protein, humanNuclear ProteinsSH2B1 protein, human

Identifiers

PMID30518945
OpenAlexW2902311328

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.